WallStSmart
BGM

Qilian International Holding Group Limited

NASDAQ: BGM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.26
-10.49% today

Updated 2026-06-05

Market cap
$58.22M
P/E ratio
P/S ratio
0.23x
EPS (TTM)
$-0.29
Dividend yield
52W range
$0 – $17
Volume
0.3M

Qilian International Holding Group Limited (BGM) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20172018201920202021202220232024
Total assets$33.38M$33.34M$35.27M$48.14M$75.35M$64.53M$51.26M$53.00M
Cash & equivalents$5.37M$5.26M$4.59M$11.87M$10.47M$14.32M$7.48M$9.82M
Current assets$21.96M$22.17M$24.97M$37.52M$40.37M$30.03M$34.51M$29.77M
Total liabilities$19.73M$15.62M$12.63M$19.30M$18.68M$9.56M$6.91M$8.91M
Current liabilities$17.97M$14.29M$11.66M$18.42M$18.17M$9.18M$6.66M$8.78M
Long-term debt
Shareholder equity$11.24M$15.32M$19.89M$26.10M$54.86M$53.05M$42.79M$42.74M
Retained earnings$3.06M$2.87M$7.56M$12.20M$14.69M$15.51M$5.90M$4.35M
Accounts receivable$1.01M$5.29M$6.14M$12.62M$13.47M$4.87M$6.35M$5.77M
Inventory$12.85M$9.59M$12.52M$11.99M$12.50M$8.88M$4.99M$5.05M
Goodwill

Frequently asked questions

What is Qilian International Holding Group Limited's revenue?

Qilian International Holding Group Limited's trailing twelve-month revenue is $29.87M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BGM?

In its most recent fiscal year, BGM ran a gross margin of 16.39%, an operating margin of -2.25%, and a net margin of -5.75%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BGM generate?

BGM produced $-3.39M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BGM's balance sheet healthy?

BGM holds $9.82M in cash and equivalents against — in long-term debt, on $42.74M of shareholder equity. That debt is best read against the cash flow the business throws off each year.